This activity has a total of three separate sections covering re-irradiation/retreatment in the CNS (both Primary CNS tumors and in the Metastatic setting), Head and Neck, and Prostate. Discussion of Volumes, Dose Constraints, and Risk/Benefit.
This activity discusses many challenging topics in the management of primary and metastatic tumors to the brain. For primary brain tumors, the primary focus will be on molecular profiling of primary brain tumors and its effect on management options of patients.
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl
This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a coding update and a scientific overview.
This eContouring session will focus on primary and secondary brain tumors, including the planning/treatment of CSI for leptomeningeal disease, brain SRS for intact and post operative brain metastases, and the treatment of glioma with a brief discussion and application of different MRI sequences.
With this activity, ASTRO continues its series of challenging case panel sessions related to palliative radiotherapy for patients with advanced cancer.
Palliative radiotherapy (RT) is a foundation of the discipline and practically represents a significant portion of most practices. The standard protocols for palliative RT (8Gy x 1, 4Gy x 5, etc.) were pioneered almost 50 years ago, when systemic therapies were far less useful.
This journal activity provides practitioners with the knowledge needed to aid in identifying which patients may benefit from brain metastasis-directed radiation therapy. Understanding these factors may help patients and their families clarify their goals of care.
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics. But despite our best efforts, evidence-based medicine cannot provide 1 clear